IO Biotech (IOBT)

IOBT was delisted on the 6th of April, 2026.

• Market cap: $3.45M
• Sector: Healthcare
• Industry: Biotechnology

About: IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Employees: 78